Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|November 16, 2019
Lessons from the Trials for the Desirable Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Diabetic Cardiovascular Events and Renal DysfunctionMasanori Wakisaka, Masahiro Kamouchi, Takanari Kitazono
Journal of the Endocrine Society|July 1, 2021
Roles of Sodium-Glucose Cotransporter 2 of Mesangial Cells in Diabetic Kidney DiseaseMasanori Wakisaka, Kuniyuki Nakamura, Toshiaki Nakano, et al.
The American Journal of Case Reports|April 20, 2018
Recovery from Diabetic Macular Edema in a Diabetic Patient After Minimal Dose of a Sodium Glucose Co-Transporter 2 InhibitorHideyuki Yoshizumi, Tetsushi Ejima, Tetsuhiko Nagao, et al.
Scientific Reports|September 2, 2024
SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosisYutaro Hirashima, Toshiaki Nakano, Kumiko Torisu, et al.
Brain Research. Molecular Brain Research|July 14, 2004
Calcium influx pathways in rat CNS pericytesMasahiro Kamouchi, Takanari Kitazono, Tetsuro Ago, et al.
Kidney International|February 12, 2004
PPARgamma ligands attenuate mesangial contractile dysfunction in high glucoseMaki Ueta, Masanori Wakisaka, Tetsuro Ago, et al.
Pageof 2